June 16, 2020 / 12:12 PM / a month ago

BRIEF-Agex Therapeutics And Pluristyx Announce Manufacturing, Marketing, And Distribution Deal

June 16 (Reuters) - AgeX Therapeutics Inc:

* AGEX THERAPEUTICS AND PLURISTYX ANNOUNCE MANUFACTURING, MARKETING, AND DISTRIBUTION AGREEMENT TO EXPAND ACCESS TO CLINICAL-GRADE HUMAN PLURIPOTENT STEM CELLS FOR THERAPEUTIC APPLICATIONS

* AGEX THERAPEUTICS -AGEX RETAINS ALL RIGHTS TO MANUFACTURE ITS OWN IN-HOUSE CELLULAR PRODUCTS & TO EXTEND LICENSE RIGHTS TO OTHER THIRD PARTIES

* AGEX THERAPEUTICS -PLURISTYX WILL MANUFACTURE,MARKET,DISTRIBUTE READY-TO-USE & READY-TO-DIFFERENTIATE ESI STEM CELL LINES VIALED,FROZEN ON BEHALF OF AGEX Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below